Laura Ferguson-Weigman
Primary Care · Bel Air, MDNPI 1306244769
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 276 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 276 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$647
- Novo Nordisk$637
- AstraZeneca$625
- Lilly USA, LLC$363
- Amgen$269
- GSK$266
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,119100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $647 |
| Novo Nordisk | 33 | $637 |
| AstraZeneca | 31 | $625 |
| Lilly USA, LLC | 24 | $363 |
| Amgen(2 entities) | 14 | $269 |
| GSK | 12 | $266 |
| Bayer | 22 | $237 |
| Otsuka America Pharmaceutical, Inc. | 8 | $187 |
| Pfizer | 10 | $171 |
| Lundbeck LLC | 7 | $145 |
| Johnson & Johnson | 6 | $139 |
| Boehringer Ingelheim | 6 | $123 |
| Grifols USA, LLC | 6 | $119 |
| E.r. Squibb & Sons, L.L.C. | 6 | $108 |
| Optinose US, Inc. | 4 | $93 |
| Harmony Biosciences LLC | 4 | $89 |
| Merck | 5 | $87 |
| Vifor Pharma, Inc. | 4 | $86 |
| Exact Sciences | 4 | $86 |
| Abbott | 4 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $67 |
| Corcept Therapeutics | 3 | $63 |
| Neurocrine Biosciences, Inc. | 3 | $61 |
| Esperion Therapeutics, Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Myriad Women's Health, Inc. | 1 | $42 |
| Dexcom, Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Baxter Healthcare | 1 | $35 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Verona Pharma, Inc. | 1 | $14 |
| Globus Medical | 1 | $14 |
How this compares
$5,119 in reported general payments places this provider in the 95th percentile of 191 primary care providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 11 | $15,563 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $880 |
| Losartan Potassium | 56 | $573 |
| Rosuvastatin Calcium | 29 | $506 |
| Atorvastatin Calcium | 62 | $504 |
| Levothyroxine Sodium | 39 | $413 |
| Metoprolol Succinate | 38 | $401 |
| Bupropion XlBupropion Hcl | 18 | $388 |
| Lisinopril | 40 | $340 |
| Pravastatin Sodium | 19 | $322 |
| Amlodipine Besylate | 61 | $319 |
| Pantoprazole Sodium | 19 | $307 |
| Duloxetine Hcl | 11 | $287 |
| Omeprazole | 14 | $246 |
| Sertraline Hcl | 17 | $230 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $625 | $15,56311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 191 primary care providers in Maryland.
Other primary care in Bel Air
- Mary WeberBel Air$3K
- Samantha MarseeBel Air$3K
- Taylor Melton-FarleyBel Air$3K
- Vicki HyattBel Air$3K
- Tara McDonaldBel Air$2K
- Donna BakerBel Air$2K
- Kimberly MorelandBel Air$2K
- Agatha HughesBel Air$2K
- Tyler CoakleyBel Air$798
- Ashley SalamoneBaltimore$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.